Hs-CRP as a biomarker for atherosclerosis progression and cardiovascular risk: a systematic review
PeerJ · 04.05.2026 · 14 · e21217
DOI: 10.7717/peerj.21217 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift PeerJ, online erschienen am 04.05.2026. Verfasst von Dalal A Al-Saedi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, College of Science, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia. Hauptthemen laut MEDLINE: C-Reactive Protein, Atherosclerosis, Cardiovascular Diseases. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
High-sensitivity C-reactive protein (hs-CRP) has emerged as a significant biomarker for assessing inflammatory activity in atherosclerosis, which may predict sudden death, especially in individuals with advanced atherosclerotic disease or those at high risk for acute events.
Methods
This systematic review aimed to evaluate the significance of changes in hs-CRP levels over time in the population with atherosclerosis; the frequency of cardiovascular events, including mortality, stroke, and myocardial infarction; and changes in the progression of atherosclerosis. We conducted a comprehensive search of the PubMed, Scopus, Web of Science, and Embase databases up to January 2026 to identify observational and cohort studies evaluating high hs-CRP levels in patients with atherosclerosis, and to evaluate the quality of studies using the Newcastle-Ottawa Scale (NOS).
Results
Our results included six studies involving baseline and follow-up hs-CRP values that showed a relationship between elevated baseline hs-CRP levels and an increased incidence of atherosclerotic progression that led to cardiovascular events. In addition, the variability in inflammation severity across different clinical events was displayed by the range of baseline hs-CRP measurements across different patient groups.
Conclusion
Universal screening for hs-CRP may improve assessment and thereby reduce the risk of cardiovascular events.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, College of Science, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
- Department of Chemistry, Faculty of Science, Al-Baha University, Al-Baha, Saudi Arabia.
- Najran Health Cluster, Najran, Saudi Arabia.
- Department of Laboratory, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
- Al Kharj Military Industries Corporation Hospital, Alkharj, Saudi Arabia.
- Al-Ghad International Health Sciences Colleges, Jeddah, Saudi Arabia.
Zitieren
APA
Al-Saedi, D. A., Al-Otaibi, K. M., Alalhareth, A., Aldurayhim, M., Alomari, A., Aljadani, B., Siddiqui, J. J., Alawaji, F., Almotiry, N. T., & Alloghbi, A. (2026). Hs-CRP as a biomarker for atherosclerosis progression and cardiovascular risk: a systematic review. PeerJ, 14, e21217. https://doi.org/10.7717/peerj.21217
Vancouver
Al-Saedi DA, Al-Otaibi KM, Alalhareth A, Aldurayhim M, Alomari A, Aljadani B, et al. Hs-CRP as a biomarker for atherosclerosis progression and cardiovascular risk: a systematic review. PeerJ. 2026;14:e21217. doi:10.7717/peerj.21217
BibTeX
@article{AlSaedi2026,
author = {Al-Saedi, Dalal A and Al-Otaibi, Kholoud M and Alalhareth, Ahmed and Aldurayhim, Mohammed and Alomari, Abdulmajeed and Aljadani, Bushra and Siddiqui, Jumana J and Alawaji, Fadi and Almotiry, Nourh T and Alloghbi, Abdurahman},
title = {Hs-CRP as a biomarker for atherosclerosis progression and cardiovascular risk: a systematic review},
journal = {PeerJ},
year = {2026},
volume = {14},
pages = {e21217},
doi = {10.7717/peerj.21217}
}
EUVIMED